Department of Endocrinology and Metabolism, Acibadem Maslak Hospital, Istanbul, Turkey.
Medical School, Bezmialem Vakif University, Istanbul, Turkey.
Horm Metab Res. 2022 Aug;54(8):556-561. doi: 10.1055/a-1804-9561. Epub 2022 Mar 22.
Subacute thyroiditis (SAT) is an inflammatory disease of the thyroid that develops following viral upper respiratory tract infections. SARS-CoV-2 virus, the cause of COVID-19, binds to the Angiotensin-Converting Enzyme-2 (ACE2) molecule expressed on the target cell surface. Thyroid gland shows high levels of ACE2 expression. The cases of SARS-CoV-2-related subacute thyroiditis and Graves' disease have been reported. It has recently been noted that vaccines for SARS-CoV-2 also induce autoimmune and inflammatory reactions. We present six (4 male, 2 female) cases of SAT that developed after mRNA and inactivated SARS-CoV-2 vaccines. And we have reviewed the literature. SAT was seen in 5 patients after mRNA vaccine, in one after inactivated vaccine. Their clinic and laboratory findings suggested to SAT. They were treated with nonsteroid anti-inflamatory drugs and/or methylprednisolone.They recovered within few weeks. Out patients did not have permanent hypothyroidism after SAT. The history of SARS-CoV-2 vaccination should be questioned in patients with subacute thyroiditis in pandemic days.
亚急性甲状腺炎(SAT)是一种甲状腺炎症性疾病,发生于病毒上呼吸道感染之后。导致 COVID-19 的 SARS-CoV-2 病毒与靶细胞表面表达的血管紧张素转换酶 2(ACE2)分子结合。甲状腺显示高水平的 ACE2 表达。已经报道了与 SARS-CoV-2 相关的亚急性甲状腺炎和格雷夫斯病病例。最近有人指出,SARS-CoV-2 疫苗也会引起自身免疫和炎症反应。我们报告了 6 例(4 男 2 女)SAT 病例,这些病例发生在 mRNA 和灭活 SARS-CoV-2 疫苗之后。并对文献进行了回顾。5 例患者在接种 mRNA 疫苗后出现 SAT,1 例在接种灭活疫苗后出现 SAT。他们的临床和实验室检查结果提示 SAT。他们接受了非甾体抗炎药和/或甲基强的松龙治疗。他们在数周内康复。SAT 后门诊患者无永久性甲状腺功能减退。在大流行期间,对于亚急性甲状腺炎患者,应询问 SARS-CoV-2 疫苗接种史。